microRNA-646 inhibits angiogenesis of endothelial progenitor cells in pre-eclamptic pregnancy by targeting the VEGF-A/HIF-1α axis.
angiogenesis
endothelial progenitor cells
microRNA-646
preeclampsia
vessel homeostasis
Journal
Experimental and therapeutic medicine
ISSN: 1792-0981
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
10
08
2018
accepted:
01
11
2019
entrez:
13
8
2020
pubmed:
13
8
2020
medline:
13
8
2020
Statut:
ppublish
Résumé
Pre-eclampsia is a complication that occurs during pregnancy, the pathological feature of which is a change in vascular endothelial homeostasis. microRNA (miR)-646 is an anti-angiogenic miRNA that has been indicated to exhibit potential anti-angiogenic effects in endothelial cells cultured
Identifiants
pubmed: 32782496
doi: 10.3892/etm.2020.8929
pii: ETM-0-0-8929
pmc: PMC7401288
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1879-1888Informations de copyright
Copyright: © Dong et al.
Références
J Cancer. 2019 May 12;10(9):1997-2005
pubmed: 31205560
J Biomed Mater Res A. 2019 Feb;107(2):423-433
pubmed: 30461195
J Biol Chem. 2013 Apr 12;288(15):10819-29
pubmed: 23423382
Placenta. 2013 Mar;34 Suppl:S62-7
pubmed: 23395298
J Mol Med (Berl). 2013 Mar;91(3):285-95
pubmed: 23371317
BMC Genomics. 2013 Mar 15;14:182
pubmed: 23496821
Annu Rev Cell Dev Biol. 2012;28:719-41
pubmed: 23057748
Circ Res. 2004 Aug 20;95(4):343-53
pubmed: 15321944
Semin Cancer Biol. 2015 Dec;35 Suppl:S224-S243
pubmed: 25600295
Nat Rev Nephrol. 2014 Aug;10(8):466-80
pubmed: 25003615
Stem Cells. 2013 Jul;31(7):1363-70
pubmed: 23554274
Clin Exp Hypertens. 2012;34(5):334-41
pubmed: 22468840
J Chin Med Assoc. 2017 Oct;80(10):615-622
pubmed: 28716604
Curr Hypertens Rep. 2013 Dec;15(6):590-9
pubmed: 24108542
Prenat Diagn. 2016 Nov;36(11):997-1008
pubmed: 27711965
Med Sci Monit. 2013 Feb 15;19:118-24
pubmed: 23416763
Med Sci Monit Basic Res. 2014 Jul 21;20:97-104
pubmed: 25047098
Mol Med Rep. 2014 May;9(5):1483-505
pubmed: 24639062
J Am Chem Soc. 2013 Jul 17;135(28):10418-25
pubmed: 23796364
Stem Cells Dev. 2014 Feb 15;23(4):319-32
pubmed: 24171705
J Clin Invest. 2014 Nov;124(11):4941-52
pubmed: 25329693
J Mol Biol. 2010 Sep 24;402(3):491-509
pubmed: 20678503
Acta Pharm Sin B. 2015 Sep;5(5):378-89
pubmed: 26579469
Curr Opin Obstet Gynecol. 2017 Dec;29(6):383-389
pubmed: 28961633
Am J Obstet Gynecol. 2015 Oct;213(4 Suppl):S115-22
pubmed: 26428489
J Clin Med Res. 2014 Feb;6(1):1-7
pubmed: 24400024
Br J Cancer. 2017 Aug 8;117(4):525-534
pubmed: 28632723
Biomed Res Int. 2013;2013:970265
pubmed: 24195082
Nat Rev Mol Cell Biol. 2014 Aug;15(8):509-24
pubmed: 25027649
Front Biosci. 2007 Jan 01;12:2383-94
pubmed: 17127248
Sci Rep. 2016 Oct 17;6:35536
pubmed: 27748453
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Physiol Rev. 2013 Oct;93(4):1743-802
pubmed: 24137021
Mediators Inflamm. 2013;2013:697972
pubmed: 23818743
J Clin Invest. 2013 Sep;123(9):3664-71
pubmed: 23999440
Trends Mol Med. 2014 Mar;20(3):154-65
pubmed: 24440002
Cell Mol Immunol. 2014 Nov;11(6):538-47
pubmed: 24954225
Br J Cancer. 2014 Sep 9;111(6):1188-200
pubmed: 25010867